Research & Development department is turning an idea into a new pharmaceutical product. For the development of new products, R&D department is working with certified laboratories in Europa and abroad. The main target is to develop a new, added value pharmaceutical product and new food supplements, which would treat the disease diagnosed by the doctor and at the same time it would be friendly to the patient to take. Many of the products developed and marketed by Rich Pharma are based on innovative compositions and pharmaceutical forms and have patented formulations.
Regulatory Affairs department is responsible for monitoring and adapting the pharmaceutical legislation. They communicate with the Health Authorities for the registration of a pharmaceutical product that has been developed by Rich Pharma in the countries of interest. The expertise of the department’s executives allows the preparations of all modules of the registration dossier according to the current legislation (e-CTD format).
Clinical trials department coordinates and monitors almost all clinical trials sponsored by Rich Pharma before registration of a pharmaceutical product or after obtaining a marketing authorization.